Rethinking the Antibiotic Discovery Paradigm-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rethinking the Antibiotic Discovery Paradigm

Published:2015-07 Issue:7 Volume:2 Page:629-630
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Hancock Robert E.W.

Funder

Canadian Institutes for Health Research

Canadian Cystic Fibrosis Foundation

National Institute of Allergy and Infectious Diseases of the National Institutes of Health

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference8 articles.

1. Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies;Fuente-Núñez;Curr. Opin. Microbiol.,2013

2. Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens;Gill;Chem. Biol. Drug Des.,2015

3. Modulating immunity as a therapy for bacterial infections;Hancock;Nat. Rev. Microbiol.,2012

4. Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant gram-negative bacterial pathogens;Lin;eBiomedicine,2015

5. Treatment of infectious disease: beyond antibiotics;Nigama;Microbiol. Res.,2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro synergy screens of FDA-approved drugs reveal novel zidovudine- and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae;Scientific Reports;2023-09-02

2. Antimicrobial Conjugated Oligoelectrolytes Containing Triphenylphosphonium Solubilizing Groups;Chemistry – A European Journal;2023-03-06

3. Small Carbohydrate Derivatives as Potent Antibiofilm Agents;Journal of Medicinal Chemistry;2022-07-01

4. Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria;Applied Microbiology and Biotechnology;2022-05-23

5. Novel synergistic combinations of last-line antibiotics and FDA-approved drugs against Klebsiella pneumoniae revealed by in vitro synergy screenings;2022-05-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3